UnitedHealth Group Incorporated $UNH Shares Sold by Waterfront Wealth Inc.

Waterfront Wealth Inc. lowered its stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 2.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,621 shares of the healthcare conglomerate’s stock after selling 68 shares during the quarter. Waterfront Wealth Inc.’s holdings in UnitedHealth Group were worth $818,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Bayforest Capital Ltd raised its position in UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd raised its position in UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 50 shares in the last quarter. Glass Jacobson Investment Advisors llc raised its position in UnitedHealth Group by 80.9% in the second quarter. Glass Jacobson Investment Advisors llc now owns 123 shares of the healthcare conglomerate’s stock worth $38,000 after acquiring an additional 55 shares in the last quarter. Kentucky Trust Co raised its position in UnitedHealth Group by 53.8% in the second quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock worth $45,000 after acquiring an additional 50 shares in the last quarter. Finally, O Brien Wealth Partners LLC raised its position in UnitedHealth Group by 74.0% in the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after acquiring an additional 37 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on UNH shares. Mizuho boosted their price objective on UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a report on Thursday, October 9th. Morgan Stanley boosted their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a report on Friday, September 12th. Cantor Fitzgerald restated an “overweight” rating and set a $440.00 price objective on shares of UnitedHealth Group in a report on Tuesday, August 26th. Piper Sandler cut their price objective on UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating on the stock in a report on Tuesday. Finally, Royal Bank Of Canada upped their target price on UnitedHealth Group from $286.00 to $408.00 and gave the company an “outperform” rating in a report on Wednesday. Eighteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $395.64.

View Our Latest Analysis on UNH

UnitedHealth Group Trading Down 3.2%

Shares of NYSE UNH opened at $356.05 on Thursday. The stock has a market cap of $322.47 billion, a price-to-earnings ratio of 18.58, a PEG ratio of 2.37 and a beta of 0.47. The business has a 50 day simple moving average of $342.00 and a 200 day simple moving average of $331.00. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating the consensus estimate of $2.87 by $0.05. The business had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The firm’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $7.15 EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s payout ratio is presently 38.30%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.